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     BSTRACT
In this article, detailed studies on antimicrobial resistance to commensal E. coli (in pigs, meat-
producing bovines, broiler chickens and veal calves) and pathogenic E. coli (in pigs and bovines) 
in Belgium are presented for 2011. Broiler chicken and veal calf isolates of commensal E. coli 
demonstrated higher antimicrobial resistance prevalence than isolates from pigs and bovines. 
Fifty percent of E. coli isolates from broiler chickens were resistant to at least five antimicrobials, 
whereas sixty-one percent of bovine E. coli isolates were susceptible to all antimicrobials tested. 
On the other hand, bovine pathogenic E. coli isolates showed an extended resistance profile 
with more than half of the isolates being resistant to ten or more antimicrobials. The results 
are not significantly different from the results from previously published studies on commensal 
bacteria in pigs in Belgium, although different methodologies of sampling and susceptibility 
testing were used. 
SAMENVATTING
In dit artikel worden gedetailleerde studies over antimicrobiële resistentie van commensale E. coli 
bij varkens, runderen, pluimvee en vleeskalveren en pathogene E. coli bij varkens en runderen 
in België beschreven voor 2011. Bij commensale E. coli-isolaten van pluimvee en vleeskalveren 
werd een hogere prevalentie van antimicrobiële resistentie vastgesteld dan bij isolaten van varkens 
en runderen. Vijftig procent van de E. coli-isolaten van vleeskuiken was resistent tegen ten minste 
vijf antimicrobiële middelen, terwijl 61% van de isolaten van runderen gevoelig was voor alle 
geteste antibiotica. Daarentegen vertoonden pathogene E. coli-isolaten van runderen een uitgebreid 
resistentieprofiel, met resistentie tegen tien of meer antimicrobiële middelen bij meer dan de helft van 
de isolaten. De resultaten zijn niet significant verschillend van de resultaten van eerder gepubliceerde 
studies over commensale bacteriën bij varkens en vleeskuikens in België, hoewel er verschillende 
methoden van bemonstering en gevoeligheidstesten werden gebruikt.
Antimicrobial resistance prevalence of pathogenic and commensal 
Escherichia coli in food-producing animals in Belgium
Prevalentie van antimicrobiële resistentie van pathogene en commensale 
Escherichia coli bij voedselproducerende dieren in België
1I. Chantziaras, 1J. Dewulf, 2F. Boyen, 1B. Callens, 2,3P. Butaye
1Veterinary Epidemiology Unit, Department of Reproduction, Obstetrics and Herd Health, Faculty of 
Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820 Merelbeke, Belgium
2Department of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent 
University, Salisburylaan 133, B-9820 Merelbeke, Belgium
3Veterinary and Agrochemical Research Center (VAR), Groeselenberg 99, B-1180 Brussels
ilias.chantziaras@ugent.be
A
INTRODUCTION
E. coli is often used as an indicator bacterium for 
the presence of antimicrobial resistance of gram- 
negative bacteria because it is present in nearly all 
animal species. Murray et al. (1992) stated that re-
sistance of commensal E. coli is an indication for the 
magnitude of the selective pressure from the use of 
antimicrobials in an animal population. Some E. coli 
strains are also major pathogens in several animal 
species. In pigs, several studies indicate that anti-
microbial resistance is higher in pathogenic than in 
commensal E. coli strains (Boerlin et al., 2005, Hen-
driksen et al., 2008)
Transfer of antimicrobial resistance from food-
producing animals to humans might happen via 
food, through environmental contamination such 
as recreational waters and by direct animal contact 
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(Wooldridge, 2012). Infections with bacteria, which 
are resistant to the antimicrobial used may result in 
treatment failures. Multi-resistance may necessitate 
the use of second-line antimicrobials for therapy, in-
creasing the expenses as well as the chance of creat-
ing multi-resistant strains (Migliori et al. 2007). The 
World Health Organization (WHO) identifies antimi-
crobial drug resistance as a global concern and high-
lights the role of monitoring programs to provide suf-
ficient data for the use in ongoing research focussing 
on combatting drug resistance. To stimulate the dis-
cussion and the research on antimicrobial resistance 
in veterinary medicine, McEwen et al. (2002) stated 
that although antimicrobial resistance is also of major 
concern for animal health, little is known about the 
magnitude of this problem. 
Given the importance of antimicrobial resistance, 
the Belgian Federal Agency for the Safety of the Food 
Chain has established a monitoring program for anti-
microbial resistance of indicator bacteria. Monitor-
ing commensal E. coli complies with the guidelines 
set by European Food Safety Authority (EFSA). This 
monitoring program is the start of an annual return-
ing program, which will allow to monitor the evolu-
tion of antimicrobial resistance, and to evaluate the 
effect of intervention measures taken. It also allows 
the comparison of national results with the results 
of other European countries (EFSA, 2012). Until 
recently, monitoring of the antimicrobial resistance 
of pathogenic E. coli in pigs and bovines has been 
performed at the Veterinary Agrochemical Research 
Centre (CODA-CERVA).
The aim of this study is to describe and summarize 
the results for the resistance of E. coli using the of-
ficial monitoring program and to compare them with 
data from other point prevalence studies on E. coli. 
For all comparisons made between different studies, 
of which the raw data were available, the same inter-
pretative criteria were applied (CLSI clinical break-
points) to enhance comparability.
 
MATERIALS AND METHODS
Monitoring of antimicrobial resistance of com-
mensal E. coli in poultry, pigs, meat-producing 
bovines and veal calves
All used sampling and analysis procedures are 
described in detail in the CODA-CERVA report on 
monitoring of antimicrobial resistance in E. coli in 
Belgium in 2011 (CODA CERVA, 2012). Briefly, 
fecal samples were collected by the inspectors of 
the FAVV-AFSCA from randomly selected, appar-
ently healthy animals belonging to different catego-
ries (broiler chickens, n=420), pigs (>3 months old, 
n=157), meat-producing bovines (>7 months old, 
n=154) and veal calves (<7 months old, n=34) during 
2011. The sampling ratio was one sample per farm. 
Isolates were identified as E. coli by Animal Health 
Care Flanders (DGZ) (inoculation on Kligler and in-
dol medium) and the Walloon Regional Association 
for the Health and Identification of animals (ARSIA) 
(OPNG test, Ureum test and indol test), and were 
then sent to the CODA-CERVA reference laboratory 
for antimicrobial resistance testing, where antimicro-
bial susceptibility was tested using a microdilution 
broth method (Trek Diagnostics©). The minimum in-
hibitory concentration (MIC) was defined as the low-
est concentration, by which no visible growth could 
be detected. The European Committee on Antimicro-
bial Susceptibility Testing (EUCAST) epidemiologi-
cal cut-off values were used to indicate breakpoints 
for resistant or susceptible isolates on fourteen anti-
microbial agents, i. e. ampicillin, chloramphenicol, 
ciprofloxacin, colistin, florfenicol, cefotaxime, gen-
tamicin, kanamycin, nalidixic acid, sulfomethoxa-
zole, streptomycin, ceftazidime, tetracycline, trime-
thoprim. Multi-resistance median, i.e.  the number of 
antimicrobials to which 50% of the strains are resis-
tant, was calculated for each animal sector.
Monitoring of antimicrobial resistance of patho-
genic E. coli in pigs and bovines
All used sampling and analysis procedures are de-
scribed in the CODA-CERVA report on pathogenic 
agents in Belgium (CODA-CERVA, 2012). Briefly, 
strains originating from diseased pigs and bovines 
that showed symptoms compatible with an E. coli 
infection, e.g. neonatal diarrhea, were isolated and 
identified at the species level by the regional veteri-
nary authorities, i.e. Dierengezondheidszorg Vlaan-
deren (DGZ) and by the Association Régionale de 
Santé et d'Identification Animales (ARSIA). After-
wards, the strains were sent to the CODA-CERVA. 
The bovine strains (all isolated from animals less 
than two weeks old) were selected on the basis of 
the presence of adhesion factors F17 and CS31A by 
agglutination (performed at ARSIA), and tellurite re-
sistance was tested for potential Stx production and 
enterohemolysin production, ruling out most strains 
having no virulence factors. For both bovine and 
porcine strains, multiplex PCR tests were performed 
at CODA-CERVA for pathotyping (for the pigs: F4, 
F5, F6, F18, F41, Sta, Stb, LT, Stx2; for the bovines: 
CNF1, CNF2, eae, vt1, vt2, Sta, F5, F17, F41). 
The antimicrobial susceptibility was measured 
using the Kirby-Bauer disk diffusion method (Neo-
Sensitabs, Rosco© tablets, Taastrup, Denmark) and 
determined according to the Clinical and Laboratory 
Standards Institute (CLSI, 2008) guidelines and the 
CLSI clinical breakpoints. For the pigs, fourteen anti-
microbials were used, while for the bovines twenty-
four. Data were interpreted as susceptible, intermedi-
ate resistant and resistant. The intermediate resistant 
strains were reclassified as resistant.
In absence of good estimates of the characteristics 
of the used tests, the authors did not take into con-
Vlaams Diergeneeskundig Tijdschrift, 2014, 83 227
sideration the sensitivity and specificity of the used 
tests. Therefore, the presented prevalence estimates 
are apparent prevalences.
 
Study comparisons: data preparation and conside- 
rations
Regarding broiler chickens, the results of the na-
tional monitoring data were compared with the data 
obtained by Persoons et al. (2010) who determined 
the susceptibility of commensal E. coli from fecal 
samples of healthy broilers. For isolation, the Kirby-
Bauer disk diffusion method (NeoSensitabs, Rosco© 
tablets, Taastrup, Denmark) was used, and the deter-
mination of antimicrobial resistance was done ac-
cording to the CLSI (2008) guidelines. In this study, 
fecal samples originating from 32 randomly selected 
broiler farms (30 samples per farm) were investiga-
ted between April 2007 and March 2008. All farms 
were visited twice (two sampling periods). In this 
comparison, the authors included the results from 
only one sampling (the second). From this sampling 
round, 912 strains were isolated. In order to make the 
comparisons valid, the raw data of the national moni-
toring of commensal E. coli in broilers were inter-
preted using the CLSI clinical breakpoints as used in 
the study by Persoons et al. (2010).
The results of the national monitoring of anti-
microbial resistance of commensal E. coli in pigs 
were compared to the results on commensal E. coli 
in pigs by Callens et al. (2010), who used the Kirby-
Bauer disk diffusion method (NeoSensitabs, Rosco© 
tablets, Taastrup, Denmark). The antimicrobial re-
sistance prevalence was determined according to the 
CLSI (2008) guidelines. In this study, 824 strains 
originating from 45 Belgian randomly selected pig 
farms were tested (20 samples per farm). All animals 
were tested once. Similarly to the data on broilers, 
the raw data on the national monitoring of commen-
sal E. coli in pigs were interpreted using the CLSI 
clinical breakpoints. The authors also compared the 
data on antimicrobial resistance of pathogenic E. coli 
with those of the national monitoring of commensal 
E. coli using the CLSI breakpoints. 
Also for fluoroquinolones -a critically important 
class of antibiotics for human medicine-, there was 
a differentiation in the choice of antimicrobials be-
tween studies. In the studies of Persoons et al. (2010) 
and Callens et al. (2010), enrofloxacin was selected 
and used, whereas in the national monitoring report 
ciprofloxacin was used  (CODA-CERVA, 2012). All 
fluoroquinolones have the same mechanism of action, 
i.e. inhibition of the topoisomerase genes leading to 
the inhibition of DNA replication (Hopkins et al., 
2005). As there is full cross-resistance between fluo-
roquinolones, the authors directly compared the resis-
tance prevalence to enrofloxacin and ciprofloxacin.
Data analysis
The antimicrobial resistance prevalence was mea-
sured for each animal sector. The exact 95% binomial 
confidence intervals were calculated.
Data manipulations and analysis were performed 
in Microsoft Excel 2010 edition. IBM SPSS Statis-
tics 21.0 was used for all statistical analysis. Differ-
ences in prevalence were studied using the Pearson's 
chi-square test or -if not suitable- the Fisher’s exact 
test. The chi-squared test was not suitable only if the 
expected values in any of the cells of a contingency 
table was below 5 (usual rule of thumb). In those 
cases, the Fisher’s exact test was preferred. Multiple 
comparisons were dealt with using the Bonferroni 
correction method for each set of comparisons.
RESULTS
National monitoring of antimicrobial resistance of 
commensal E. coli 
In this study, 420 isolates from broiler chickens, 
157 from pigs, 154 from meat-producing cattle and 
34 from veal calves were collected. The antimicrobial 
resistance results are presented for each animal sector 
in Figure 1. For broiler chickens, the antimicrobial 
resistance to ampicillin rose above 80%. For nali-
dixic acid, ciprofloxacin, sulphomethoxazole, tetra- 
cycline, streptomycin and trimethoprim, the antimi-
crobial resistance prevalence was higher than 60% 
but lower than 80%. Due to the importance of cepha-
losporins to human medicine, the 19% and the 10% 
antimicrobial resistance prevalences to the cephalo-
sporins cefotaxime and ceftazidime, respectively, are 
noteworthy. For pigs, the resistance prevalence was 
above 50% to ampicillin, sulphomethoxazole, tetra-
cycline, and trimethoprim. For bovines, the highest 
antimicrobial resistance prevalence was seen to sul-
phonamides and ampicillin, with a resistance preva-
lence of approximately 25%. Concerning veal calves, 
the resistance prevalence was higher than in pigs and 
bovines. More than 70% of the strains were resistant 
to ampicillin, sulphonamides, tetracycline and trime-
thoprim. As for veal calves, no cephalosporin resis-
tance was found.
Multi-resistance median and strain susceptibility 
prevalences are presented in Table 1. For broiler 
chickens and veal calves, more than 50% (multi-re-
sistance median) of the E. coli strains acquired re-
sistance to at least five antimicrobials. For pigs, the 
multi-resistance median was three; for bovines, more 
than 50% of the strains were fully susceptible to all 
antimicrobials. Considering the isolates from broiler 
chickens in more detail, for ESBL suspected strains, 
the multi-resistance median was 6.5 antimicro- 
bials and for AmpC suspected strains, the median 
was eight antimicrobials.  
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AMP: ampicillin, CHL: chloramphenicol, CIP: ciprofloxacin, COL: colistin, FFN: florfenicol, FOT: cefotaxime, GEN: 
gentamicin, KAN: kanamycin, NAL: nalidixic acid, SMX: sulfomethoxazole, STR: streptomycin, TAZ: ceftazidime, TET: 
tetracycline, TMP: trimethoprim 
Figure 1. Indicator Escherichia coli isolates’ resistance prevalence to fourteen antimicrobial agents, with exact 95% 
binomial confidence intervals. Four animal sectors were studied. The micro broth dilution method was used and epi-
demiological cut-off values were applied to determine the antimicrobial resistance prevalence, according to EUCAST 
standards. Significant differences (P<0.05) between studies are indicated with * (P-value was observed at 5%). Mul-
tiple comparisons were dealt with using the Bonferroni correction method for each set of comparisons.
AMP: ampicillin, AMO-CLA: amoxycillin- clavulanic acid, TET: tetracycline, TMP: Trimethoprim, SUL: sulfonamide, 
TIO: ceftiofur, NAL: nalidixic acid, ENR: enrofloxacin, APR: apramycin, NEO: neomycin, GEN: gentamycin, CHL: 
chloramphenicol,  FFN: florfenicol
Figure 2. VAR report, pathogenic E. coli antimicrobial resistance prevalence in pigs and bovines in 2011. Additionally, 
the bars represent the exact 95% binomial confidence intervals of the prevalence results. The disk diffusion method 
was used and clinical breakpoints (CLSI standards) were implemented. Only antimicrobial agents that were com-
monly tested in both animal species are displayed in this figure. Significant differences between studies are indicated 
with * (P-value was observed at 5%). Multiple comparisons were dealt with using the Bonferroni correction method 
for each set of comparisons.
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Monitoring of pathogenic E. coli from pigs and 
bovines 
A total of 135 pig strains were retrieved, of which 
133 were analyzed for virulence characteristics by 
PCR. In the majority of them (76/133), no virulence 
genes could be detected. The most prevalent patho-
type was ETEC (Table 2). Few strains were positive 
for F41, F5 or F6 fimbriae. F4 was the most prevalent 
adhesion factor, followed by F18. Of the ETEC asso-
ciated toxins, STb was the most prevalent. Hemolysis 
was seen in approximately 60% of the strains. Nearly 
90% of the pathogenic strains were hemolytic. As 
for bovines, 545 strains were obtained, and the vast 
majority of them (468/565) were colonizing strains 
(Table 2). Regarding associations with adhesion fac-
tors, NTEC strains were mainly associated with F17 
and CS31A. All but one STa strain were associated 
with F5 fimbriae. Of the 10 VTEC strains, six were 
associated with VT1, 3 with VT2 and one with both 
VT1 and VT2. EPEC strains were associated with F5 
and/or F41. The majority of colonizing strains was 
CS31A or F17 positive. 
Antimicrobial resistance prevalence for pigs and 
bovines are shown in Figure 2. The multi-resistance 
median for pigs was five out of 15 antimicrobials, 
and the strains that were fully susceptible were less 
than 8%. For bovines, the multi-resistance median 
was ten out of 24 antimicrobials, and the strains that 
remained fully susceptible to all antimicrobials were 
almost 4%.
Study comparisons
Comparing the data of the national monitoring 
of the antimicrobial resistance of commensal E. coli 
from broilers with the data obtained from the study 
by Persoons et al. (2010), it was revealed that only 
the resistance prevalence to streptomycin was signifi-
Table 1. Commensal Escherichia coli strain antimicrobial susceptibility prevalence, multi-resistance and main findings 
for each animal sector included 
Animal sector Strain susceptibility  Multi-resistance medianb
 prevalencea
Broiler chickens 6.2 % 5 AMsc
  (6.5 for ESBL-suspected strains, 8 for AmpC-suspected strains)
Pigs 22.3 % 3 AMs
Bovines 61 % 0 AMs
  (5 for cephalosporin-resistant strains, 5 for FFN-resistant strains)
Veal calves 14.7 % 5 AMs
  (7 for colistin-resistant strains)
a : Percentage of the strains that remained fully susceptible to all antimicrobials
b : Number of antimicrobials, to which 50% of the strains were resistant
c : AMs = Antimicrobial agents; FFN=florfenicol
Table 2. Pathotypes found in pathogenic E. coli strains from pigs and bovines in 2011.
Pathotype Number of strains (pigs) Number of strains (bovines)
Colonizing strains 5 468
ETEC 35 11
VTEC 8 10
ETEC/VTEC 1 1
ETEC without attachment factor 8 -
NTEC - 12
No virulence gene/ factor detected 76 35
No final conclusion possible1 - 5
Total number of strains 133 542 
1: this applies only for bovine E. coli strains due to the different pathotyping technique used
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AMP: ampicillin, NAL: nalidixic acid, TET: tetracycline, 
STR: streptomycin, CHL: chloramphenicol, ENR¹: enro-
floxacin (national monitoring report used ciprofloxacin), 
GEN: gentamycin, FFN: florfenicol 
Figure 3. Indicator E. coli resistance in poultry. Com-
parison of the VAR report and the study of Persoons et 
al. (2010) is presented. Data harmonization with CLSI 
breakpoints for clinical resistance was applied to both 
datasets. The bars represent the exact 95% binomial 
confidence intervals of the prevalence results. Signifi-
cant differences between both studies are indicated with 
* (P-value was observed at 5%). Multiple comparisons 
were dealt with using the Bonferroni correction method 
for each set of comparisons.
AMP: ampicillin, NAL: nalidixic acid, TET: tetracycline, 
STR: streptomycin, CHL: chloramphenicol, GEN: genta-
mycin, FFN: florfenicol, ENR¹: enrofloxacin (national 
monitoring report used ciprofloxacin), SMX: sulfometh-
oxazole, TMP: trimethoprim, KAN: kanamycin
Figure 4. Indicator E. coli resistance in pigs. Compari-
son of the VAR report and the study of Callens et al. 
(2010) is presented. Data harmonization with CLSI 
breakpoints for clinical resistance was applied to both 
datasets. 
The bars represent the exact 95% binomial confidence 
intervals of the prevalence results. Significant differ-
ences between both studies are indicated with * (P-
value was observed at 5%). Multiple comparisons were 
dealt with using the Bonferroni correction method for 
each set of comparisons.
cantly different  (P <0.05)  in the national monitoring 
report. Comparing the data of Callens et al. (2010) 
with the national monitoring of commensal E. coli 
from pigs, the only statistically significant difference 
found was for nalidixic acid (P <0.05), which was 
higher in the national monitoring report (Figures 3 
and 4). Finally, the authors compared the VAR com-
mensal study and the pathogenic E. coli study on pigs 
and bovines (Figures 5 and 6). For pigs,  significantly 
(P <0.05) different antimicrobial resistance preva-
lences were shown in the pathogenic E. coli study 
to ampicillin, sulphamethoxazole, tetracycline and 
nalidixic acid. For bovines, significantly (P <0.05) 
different prevalences in the pathogenic E. coli study 
were seen for ampicillin, sulphamethoxazole, tetra-
cycline, nalidixic acid, trimethoprim, streptomycin, 
fluoroquinolones, chloramphenicol, kanamycin, gen-
tamicin and florfenicol.
DISCUSSION
Commensal E. coli
In the Belgian national monitoring program on 
antimicrobial resistance of commensal E. coli, sam-
ples were collected from broiler chickens, pigs, veal 
calves and bovines. Compared to other national moni- 
toring programs conducted in European countries in 
2010-2011, this was the only report- alongside with 
the MARAN report- that included data on the four 
major animal sectors, which complied with the EFSA 
guidelines (Chantziaras et al., 2013).  In addition, the 
number of samples and the sampling protocol were 
-with the exception of veal calves- comparable with 
other national monitoring reports conducted in the 
same year, thus allowing a representative overview of 
the resistance situation (Bywater et al., 2004). How-
ever, a further increase of the number of samples will 
improve the power of the study regarding the analys-
ing trends on antimicrobial resistance. 
When comparing the results between animal spe-
cies for commensal E. coli, veal calf isolates showed 
the highest antimicrobial resistance prevalence for 
eight antimicrobial agents. However, the low number 
of veal calf samples that were included, resulted in 
large confidence intervals. Hence, when compared to 
the other three animal sectors, the resistance preva-
lence results were not significantly different from 
those in broiler chickens or in pigs. Only when com-
pared with bovines, and for all antimicrobials except 
cefotaxime and ceftazidime, the resistance preva-
lence was significantly higher for veal calves iso-
lates. This difference is likely due to the very high 
use of antimicrobials in the veal production system 
(Pardon et al., 2013, Berge et al., 2010, Sato et al., 
2005). Another possible explanation has been given 
by Walk et al. (2007). They suggest that the fitness 
cost of resistant bacteria becomes too large as the 
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host gastrointestinal tract matures and competition 
with other microbes increases. 
Due to the importance for human medicine, the 
almost 15% antimicrobial resistance prevalence to 
colistin is to be noted. The colistin-resistant strains 
were highly multi-resistant, all of them being re-
sistant to at least seven more antimicrobial agents. 
Gram-negative bacteria may develop resistance to 
colistin through chromosomal mutation or adaptation 
mechanisms rather than through a horizontal spread 
of mobile genetic elements (MGEs) carrying resis-
tance genes (Falagas et al., 2005). 
Broiler chicken isolates showed the highest anti- 
microbial resistance prevalence to the other six 
agents. The antimicrobial resistance prevalence to 
quinolones was higher than in the other animal spe-
cies. Moreover, resistance to ceftazidime and cefo-
taxime was high, reaching a 20% prevalence for each 
of the cephalosporins. A closer look into multi-resis-
tance patterns of the isolates provided valuable in-
formation. All ceftazidime-resistant strains were also 
resistant to cefotaxime. As shown in Table 1, there is 
a high multi-resistance pattern of the cephalosporin 
resistant strains. Due to the particular importance of 
cephalosporins for human health, molecular epide-
miology analysis and further testing, e.g. the detec-
tion of plasmid-mediated genes, of the strains in such 
studies are warranted. After comparing the results of 
the national monitoring study for broilers with the 
results of the study of Persoons et al.(2010), no sig-
nificant differences were found with the exception of 
streptomycin resistance, which was more prevalent 
in the results of the national monitoring report. This 
difference may be attributed to the accuracy of the 
disk diffusion method for streptomycin. Comparing 
the national monitoring study for pigs and the respec-
tive study of Callens (2010), only a small, yet signifi-
cant difference was seen for nalidixic acid, of which 
the prevalence was higher in the national monitoring 
report (Figure 5). Contrary to the national monitoring 
study, all studies that used the disk diffusion method, 
did not test colistin as several publications have 
proved that the poor agar diffusion characteristics of 
colistin limit the accuracy of the disk diffusion test 
(Gales et al., 2001; Lo-Ten-Foe et al., 2007, Galani et 
al., 2008). In general, the monitoring of commensal 
E. coli did not show many statistically significant dif-
ferences between the national monitoring and the two 
selected point prevalence studies, both confirming 
the high antimicrobial resistance prevalence in Bel-
gium. This agreement suggests that both the studies 
and the monitoring program were capable of describ-
ing the general level of resistance in a representative 
manner. It may therefore be concluded that the de-
scribed resistance levels of commensal E. coli in pigs 
and broilers are truly the current level of resistance, 
and are therefore a good reference point to check for 
evolutions in the coming years. Nevertheless, all of 
the comparisons also revealed that even when using 
Figure 6. Comparison of the VAR pathogenic E. coli 
study and the VAR commensal E. coli study. Data were 
collected from bovine strains. Data harmonization with 
CLSI breakpoints for clinical resistance was applied to 
both datasets. 
The bars represent the exact 95% binomial confidence 
intervals of the prevalence results. Significant differ-
ences between studies are indicated with * (P-value was 
observed at 5%). Multiple comparisons were dealt with 
using the Bonferroni correction method for each set of 
comparisons.
different methods, a certain level of harmonization 
between the E. coli studies may be reached, acknow-
ledging on beforehand the limitations that can be seen 
for some antimicrobials, e.g. colistin, streptomycin. 
Besides the methods used, special attention should 
also be drawn to the harmonization of sampling 
methods, age of animals and number of samples.
AMP: ampicillin, SMX: sulfomethoxazole, TET: tetracy-
cline,  NAL: nalidixic acid, STR: streptomycin, ENR¹: en-
rofloxacin (national monitoring report used ciprofloxacin), 
CHL: chloramphenicol, GEN: gentamycin, FFN: florfe-
nicol
Figure 5. Comparison of the VAR pathogenic E. coli 
study and the VAR commensal E. coli study. Data were 
collected from pig strains. Data harmonization with 
CLSI breakpoints for clinical resistance was applied to 
both datasets. 
The bars represent the exact 95% binomial confidence 
intervals of the prevalence results. Significant differences 
between both studies are indicated with * (P-value was 
observed at 5%). Multiple comparisons were dealt with 
using the Bonferroni correction method for each set of 
comparisons.
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Pathogenic E. coli reports 
Regarding the antimicrobial profile of the patho-
genic E. coli isolates, pathogenic E. coli strains from 
bovines are more resistant to antimicrobials than 
those from pigs, as shown in Figure 2. Antimicrobial 
resistance to florfenicol was five times higher than  in 
pigs, four times higher to neomycin and gentamicin 
and two times higher to chloramphenicol. No signifi-
cant differences were seen for trimethoprim and its 
combination with sulphonamides, apramycin, ceftio-
fur and ampicillin. The use of the most recently intro-
duced antimicrobials in veterinary medicine seems 
to have already been compromised in pathogenic E. 
coli, especially for strains isolated from bovines. 
Strains resistant to cephalosporins and strains re-
sistant to amoxicillin with clavulanic acid were clearly 
associated with multi-resistance. Co-resistance to 
ceftiofur was seen in 23 cases suggesting the pres-
ence of CMY encoding genes or other genes. Further 
testing is warranted, as these antimicrobials are criti-
cally important for human and veterinary medicine.
Several authors (Boerlin et al., 2005; Hendriksen 
et al., 2008) have shown that antimicrobial resistance 
more frequently occur in pathogenic than in com-
mensal E. coli strains from pigs. When comparing the 
commensal and the pathogenic E. coli VAR studies, 
pathogenic strains were significantly more resistant 
to four out of ten antimicrobials (ampicillin, tetracy-
cline, sulphonamides and nalidixic acid) in pigs (Fig-
ure 5). As for bovine strains, the differences between 
the antimicrobial resistance prevalence were more 
evident and more numerous (pathogenic strains were 
significantly more resistant to eleven out of twelve 
antimicrobials that were commonly tested) (Figure 
6). It should be mentioned that for the pathogenic 
E. coli studies, isolates were collected from clinical 
cases. Age of the animals, genetic background of the 
E. coli isolates and possible previous administration 
of antimicrobials to the clinically ill animals could 
partially explain these differences. Hence, when see-
ing the differences in resistance prevalence between 
commensal and pathogenic E. coli, it appears that the 
results of one study cannot be used to predict the ex-
pected prevalence levels of the other and vice versa.
CONCLUSIONS
In 2011, a large scale national monitoring program 
on antimicrobial resistance of commensal and along-
side with the pre-existing program concerning zoo-
notic bacteria was launched in Belgium. Antimicro-
bial resistance of commensal E. coli varied between 
animal species. Comparing the results from com-
mensal E. coli point prevalence studies in research 
projects, using a different sampling and susceptibility 
testing methodology, the authors revealed that the 
results were highly comparable. Pathogenic E. coli 
strains both from bovines and pigs were more patho-
genic than the respective commensal E. coli strains. 
REFERENCES
Berge, A.C., Hancock, D.D., Sischo, W.M., Besser, T.E., 
(2010). Geographic, farm, and animal factors associated 
with multiple antimicrobial resistance in fecal Esche-
richia coli isolates from cattle in the western United 
States. Journal of American Veterinary Medical Asso-
ciation 236, 1338-1344.
Boerlin, P., Travis R., Gyles C. L., Reid-Smith R., Janecko 
N., Lim H.,. Nicholson V, McEwen S. A., Friendship R., 
Archambault M. (2005). Antimicrobial resistance and 
virulence genes of Escherichia coli isolates from swine 
in Ontario. Applied and Environmental Microbiology 
71, 6753-6761.
Bywater R., Deluyker H., Deroover E., de Jong A,. Mar-
ion H., McConville M., Rowan T., Shryock T., Shuster 
T., Thomas V., Valle M., Walters J. (2004). A European 
survey of antimicrobial susceptibility among zoonotic 
and commensal bacteria isolated from food-producing 
animals. Journal of Antimicrobial Chemotherapy 54, 
744-754.
Callens B., Persoons D., Boyen F., Haesebrouck F., Dewulf 
J. (2010). Antimicrobial use and antimicrobial resis-
tance in Escherichia coli from 45 Flemish pig herds. 
Eightteenth Annual Conference of the Flemish Society 
for Veterinary Epidemiology and Economics (FSVEE), 
KATHO Roeselare, Belgium.
Chantziaras I., Boyen F., Callens B., Dewulf J. (2013). Cor-
relation between veterinary antimicrobial use and anti-
microbial resistance in food-producing animals: a report 
on seven countries. Journal of Antimicrobial Chemo- 
therapy 69, 827-834. 
CLSI (2008). Performance Standards for Antimicrobial 
Disk and Dilution Susceptibility Tests for Bacteria Iso-
lated From Animals. Approved Standard- Third edition, 
p.65-72.
CODA-CERVA (2012). Belgian Veterinary and Agro-
chemical Research Centre 2011 report. Report on zoo-
notic agents in Belgium.
 Available at: http://www.coda-cerva.be/images/pdf/
trends%20and%20sources%202010-2011.pdf (25 May 
2014, date last accessed). 
EFSA (2012). The European Union Summary Report on 
antimicrobial resistance in zoonotic and indicator bac-
teria from humans, animals and food in 2010. Available 
at: http://www.efsa.europa.eu/en/efsajournal/doc/2598.
pdf, date last accessed 26 September 2013). 
Falagas, M. E., Kasiakou S. K., Saravolatz L. D. (2005). 
Colistin: the revival of polymyxins for the management 
of multidrug-resistant gram-negative bacterial infec-
tions. Clinical Infectious Diseases 40, 1333-1341.
Galani, I., Kontopidou F., Souli M.,. Rekatsina P.-D, Ko-
ratzanis E., Deliolanis J., Giamarellou H. (2008). Co-
listin susceptibility testing by Etest and disk diffusion 
methods. International Journal of Antimicrobial Agents 
31, 434-439.
Gales, A. C., Reis A. O., Jones R. N. (2001). Contempo-
rary assessment of antimicrobial susceptibility testing 
methods for polymyxin B and colistin: review of avail-
able interpretative criteria and quality control guidelines. 
Vlaams Diergeneeskundig Tijdschrift, 2014, 83 233
Journal of Clinical Microbiology 39, 183-190.
Hendriksen, R. S., Mevius D. J., Schroeter A., Teale C., 
Jouy E., Butaye P., Franco A., Utinane A., Amado A., 
Moreno M., Greko C., Stark K. D., Berghold C.,. Myl-
lyniemi A. L, Hoszowski A., Sunde M., Aarestrup F. M. 
(2008). Occurrence of antimicrobial resistance among 
bacterial pathogens and indicator bacteria in pigs in dif-
ferent European countries from year 2002 - 2004: the 
ARBAO-II study. Acta Veterinaria Scandinavica 50, 19.
Hopkins, K. L., Davies R. H.,Threlfall E. J. (2005). Mecha- 
nisms of quinolone resistance in Escherichia coli and 
Salmonella: Recent developments.International Journal 
of Antimicrobial Agents 25(5), 358-373.
Lo-Ten-Foe, J. R., de Smet A. M. G., Diederen B. M., 
Kluytmans J. A., van Keulen P. H. (2007). Comparative 
evaluation of the VITEK 2, disk diffusion, Etest, broth 
microdilution, and agar dilution susceptibility testing 
methods for colistin in clinical isolates, including 
heteroresistant Enterobacter cloacae and Acinetobacter 
baumannii strains. Antimicrobial agents and chemo-
therapy 51(10): 3726-3730 
McEwen, S. A., Fedorka-Cray P. J. (2002). Antimicrobial 
use and resistance in animals. Clinical Infectious Dis-
eases 34 (Supplement 3), 93-106.
Murray, B. E. (1992). Problems and dilemmas of antimi-
crobial resistance. Pharmacotherapy: The Journal of 
Human Pharmacology and Drug Therapy 12, 86-93.
Migliori, G., R. Loddenkemper, F. Blasi Raviglione M. 
(2007). 125 years after Robert Koch's discovery of the 
tubercle bacillus: the new XDR-TB threat. Is “science” 
enough to tackle the epidemic? European Respiratory 
Journal 29(3), 423-427.
Persoons, D., Dewulf J., Smet A., Herman L., Heyn-
drickx M., Martel A., Catry B., Butaye P., Haesebrouck 
F. (2010). Prevalence and persistence of antimicrobial 
resistance in broiler indicator bacteria. Microbial Drug 
Resistance 16(1), 67-74.
Sato, K., Bartlett, P.C., Saeed, M.A., (2005). Antimicro-
bial susceptibility of Escherichia coli isolates from dairy 
farms using organic versus conventional production 
methods. Journal of American Veterinary Medical As-
sociation 226, 589-594.
Walk, S.T., Mladonicky, J.M., Middleton, J.A., Heidt, A.J., 
Cunningham, J.R., Bartlett, P., Sato, K., Whittam, T.S., 
(2007). Influence of antibiotic selection on genetic com-
position of Escherichia coli populations from conven-
tional and organic dairy farms. Applied Environmental 
Microbiology 73, 5982-5989.
WHO (2012). Antimicrobial resistance. Available at: 
http://www.who.int/mediacentre/factsheets/fs194/en/ 
(08 September 2013, date last accessed). 
Wooldridge M. (2012). Evidence for the circulation of 
antimicrobial-resistant strains and genes in nature and 
especially between humans and animals. Revue Scienti-
fique et Technique 31(1), 231-247.
Uit het verleden
HET SNIJDEN DER KOEIEN ( UIT: “DE BOER”, 1902)
“De uitbreiding, welke de melknijverheid genomen heeft in ons land, heeft het belang groter ge-
maakt dat wij hechten aan alle middels welke kunnen helpen om de voortbrengst der grondstof, de 
melk, te vermeerderen. Om die reden willen wij een woord zeggen aangaande ene behandeling die in 
landen waar veel gekweekt wordt, sinds lang in voege is, maar bij ons om zo te zeggen nog onbekend 
is: het snijden der koeien.
Het snijden heeft bij het vrouwelijk dier dezelfde gevolgen als bij het mannelijke. Met het geslacht-
sleven uit te dooven, richt men al de levenskrachten van het lichaam naar het groeivermogen. In één 
woord, het snijden verzekert een betere benuttiging van het ingenomen voedsel, en als onmiddellijk 
gevolg, een vermeerdering van de opbrengst van het dier. Bij het slachten is de zuivere opbrengst 5 
tot 6 % groter dan bij dieren die gevet worden in den staat der drachtigheid. 
Wat de melkopbrengst betreft, geven gesneden koeien in het jaar dat volgt op deze 
behandeling,tenminste 1300 tot 1400 liters meer melk. Wat meer is: de melk ondergaat ene wijziging 
in haar hoedanigheid. Haar rijkdom in boterstoffen vermeerdert en haar samenstelling is bestendiger 
want ze ondergaat geen verandering meer onder invloed van tochtigheid, drachtigheid en kalftijd.
De voornaamste voorwaarde om te gelukken in het snijden van koeien is het tijdstip. Deze be-
handeling moet gebeuren zes weken tot twee maanden na het kalven terwijl de koe in volle melk-
gevigheid is. Tenzij in bijzondere omstandigheden, is de voordeligste ouderdom tussen 7 en 8 jaar. 
Tegenwoordig kan deze behandeling, dank aan de vooruitgang der ontsmettingsleer, gedaan worden 
zonder enig gevaar van verwikkeling.” 
Uit: “100 jaar Boerenbond in Beeld” 
Luc Devriese
